Skip to main content
Medical information Clinical review pending

Cytogenetics

Chromosome Analysis for Hematologic Malignancy Test

Chromosome Analysis for Hematologic Malignancy Test helps diagnose blood cancers like leukemia and lymphoma by detecting chromosomal abnormalities. Essential for guiding treatment and understanding prognosis.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
2-3 mL heparinized Bone Marrow or 3 mL whole blood in a Green Top (Sodium Heparin) tube.
Results
Reports are typically available within 4 working days after sample receipt.
Preparation
Confirm with the laboratory before booking. Specific instructions may be provided by your doctor.
Test priceKSh 10,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Chromosome Analysis for Hematologic Malignancy Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Suspected leukemia or lymphoma
  • ✓Unexplained fatigue or weakness
  • ✓Recurrent infections
  • ✓Easy bruising or bleeding
  • ✓Monitoring response to cancer therapy
  • ✓Family history of hematologic malignancy
02

In plain language

What this test helps you understand

Detects chromosomal abnormalities associated with blood cancers (leukemia, lymphoma). Guides treatment decisions and helps predict prognosis.
The Chromosome Analysis for Hematologic Malignancy Test is a key diagnostic tool used to identify chromosomal abnormalities linked to blood cancers, including leukemia and lymphoma. This analysis is crucial for informing treatment decisions and understanding potential patient outcomes.

This test examines genetic material from bone marrow or blood samples to detect specific chromosomal changes that can indicate the presence or development of hematologic malignancies.

Individuals experiencing symptoms like persistent fatigue, frequent infections, unusual bruising, or bleeding might be recommended for this test. Consulting a healthcare provider is advised for those with a family history of blood cancers or other relevant risk factors to determine if this analysis is necessary.

Benefits of this test include aiding in the early detection of blood cancers, guiding the selection of appropriate treatment strategies, monitoring the progression of the disease and response to therapy, and providing valuable information for personalized medicine approaches.

Understanding the results requires discussion with a specialist, such as a hematologist, who can interpret the findings in the context of your overall health and discuss potential treatment options.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationConfirm with the laboratory before booking. Specific instructions may be provided by your doctor.
Sample2-3 mL heparinized Bone Marrow or 3 mL whole blood in a Green Top (Sodium Heparin) tube.
MethodologyCytogenetic analysis (Karyotyping) of chromosomes from bone marrow or blood cells.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects chromosomal abnormalities but may not identify all genetic changes associated with hematologic malignancies. Results must be interpreted by a qualified healthcare professional.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

A hematologic malignancy is a cancer that starts in the blood-forming tissue, such as the bone marrow. Examples include leukemia and lymphoma.
This test helps diagnose blood cancers by identifying specific chromosomal changes. This information is vital for planning the right treatment.
The test requires either a bone marrow sample or a whole blood sample collected in a specific type of tube.
Results are generally available within 4 working days after the laboratory receives the sample.
A qualified healthcare professional, typically a hematologist or medical geneticist, will interpret the results and discuss them with you.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp